What groups are at risk for contracting this disease?
*IV drug users
*people who practice unsafe sex
*health care workers
*hemodialysis patients
*infants born to infected mothers
“Although [the hepatitis B virus] is present in moderate concentrations in saliva, it?s not transmitted commonly by casual contact,” said Eric Mast, M.D., the Chief of the Surveillance Section, Hepatitis Branch of the Centers for Disease Control and Prevention (CDC) (1997 public hearing).
According to the October 31, 1997, issue of Morbidity and Mortality Weekly Report (MMWR), published by the CDC, “Hepatitis B continues to decline in most states, primarily because of a decrease in the number of cases among injecting drug users and, to a lesser extent, among both homosexuals and heterosexuals of both sexes.”
Most children do not fall into any of these categories.
Hepatitis B Incidence Low in the US and is Particularly Low in Children
The US has always had among the lowest rates of hepatitis B disease in the world, affecting approximately 0.1% to 0.5% of the general population (National Vaccine Information Center). The CDC estimates a 5% lifetime risk of infection in the United States. Of that 5%, between 90-95% will fully recover, clearing the virus from their bodies. Only the remaining 5 -10% (of the original 5%) may become chronic carriers. This means that the overall lifetime risk of becoming a chronic carrier of hepatitis B is approximately one quarter of one percent (.25%) of the entire U.S. population, leaving 99.75% of the total population at no significant risk.
The CDC acknowledges “...an estimated 91% of hepatitis B infections in the U.S. are acquired during adolesence and adulthood and much of the public health benefit of widespread infant vaccination will not be known until vaccinated infants become adolescents and adults” (MMWR, vol.43, no. 33, August 26, 1994, p.608).
Pregnant women in Massachusetts are routinely screened for hepatitis B disease. This allows for at-risk newborns to be appropriately treated.
Vaccine Effectiveness
One pharmaceutical company, Merck & Co., states in their 1996 hepatitis B vaccine product insert that “...the duration of the protective effect of [our product] in healthy vaccinees is unknown at present and the need for booster doses is not yet defined.” The CDC concurs. With a vaccine that likely confers only 7, or optimistically 10, years of protection, most children who received the hepatitis B vaccine will not be protected as they approach ages at which higher risk behaviors become more prevalent.
Vaccine Safety
Merck & Co. included the following disclaimers on its 1996 hepatitis B vaccine package insert:
“As with any vaccine, there is the possibility that broad use of the vaccine could reveal adverse reactions not observed in clinical trials.”
What they fail to explain is that the clinical trials in question involved only several thousand children, and that those children were monitored for reactions for only four or five days.
The insert continues:
“...it is not known whether the vaccine can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity;” and
“Specific data are not yet available for the simultaneous administration of [our hepatitis B vaccine] with other vaccines.” It is, however, frequently given with other vaccines.
Consumers, Doctors and Governments Question Hepatitis B Vaccine
A September, 1998 report entitled Hepatitis B Vaccine: The Untold Story, available from the National Vaccine Information Center, contains thirty-eight citations of medical articles that discuss hepatitis B vaccine as the cause of chronic immune and neurological disease in both children and adults, including: diabetes, arthritis, chronic fatigue immune deficiency, multiple sclerosis, alopecia (hair loss), lupus, Guillain-Barre syndrome, and demyelinating neuropathy.
“Considering the low risk of hepatitis B, and the published reports of serious adverse effects of the vaccine, why can’t school mandates wait for more research?” asks Jane Orient, M.D., Executive Director of the Association of American Physicians and Surgeons. “Mandates effectively use school children as research subjects without informed consent, in violation of the Nuremberg Code.”
Bonnie Dunbar M.D., a molecular biologist at Baylor College of Medicine in Houston, has said, “I am horrified by what I am seeing on this issue. I can’t believe this is happening in this country. “Public Health” is being used as a rationale to undermine individual responsibility and to legitimize intrusion on family autonomy.”
For further information, visit the National Vaccine Information Center’s hepatitis B webpage.
You can also visit the Center for Disease Control’s hepatitis B webpage.
View the vaccine package insert for the hepatitis B vaccine given to children in the Commonwealth.
Click here for the vaccine package insert for the hepatitis B vaccine given to adults in the Commonwealth.